
Joseph F. Murphy
Examiner (ID: 6409)
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1644, 1646 |
| Total Applications | 357 |
| Issued Applications | 157 |
| Pending Applications | 90 |
| Abandoned Applications | 110 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4415986
[patent_doc_number] => 06194162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Method of screening for compounds that bind P2x receptor'
[patent_app_type] => 1
[patent_app_number] => 9/363745
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 29
[patent_no_of_words] => 10169
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194162.pdf
[firstpage_image] =>[orig_patent_app_number] => 363745
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/363745 | Method of screening for compounds that bind P2x receptor | Jul 29, 1999 | Issued |
Array
(
[id] => 1157926
[patent_doc_number] => 06762290
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-13
[patent_title] => 'High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/364540
[patent_app_country] => US
[patent_app_date] => 1999-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13362
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/762/06762290.pdf
[firstpage_image] =>[orig_patent_app_number] => 09364540
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364540 | High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors | Jul 28, 1999 | Issued |
Array
(
[id] => 1018160
[patent_doc_number] => 06891028
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-10
[patent_title] => 'Nucleic acids encoding transferrin receptor-like proteins'
[patent_app_type] => utility
[patent_app_number] => 09/358755
[patent_app_country] => US
[patent_app_date] => 1999-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 9880
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/891/06891028.pdf
[firstpage_image] =>[orig_patent_app_number] => 09358755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/358755 | Nucleic acids encoding transferrin receptor-like proteins | Jul 21, 1999 | Issued |
Array
(
[id] => 1113352
[patent_doc_number] => 06803448
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-12
[patent_title] => 'GBS toxin receptor'
[patent_app_type] => B1
[patent_app_number] => 09/359167
[patent_app_country] => US
[patent_app_date] => 1999-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 31225
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/803/06803448.pdf
[firstpage_image] =>[orig_patent_app_number] => 09359167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/359167 | GBS toxin receptor | Jul 20, 1999 | Issued |
Array
(
[id] => 4219447
[patent_doc_number] => 06087488
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Potassium ion channel genes and proteins'
[patent_app_type] => 1
[patent_app_number] => 9/351215
[patent_app_country] => US
[patent_app_date] => 1999-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 13678
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087488.pdf
[firstpage_image] =>[orig_patent_app_number] => 351215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/351215 | Potassium ion channel genes and proteins | Jul 11, 1999 | Issued |
Array
(
[id] => 1235388
[patent_doc_number] => 06689581
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-10
[patent_title] => 'Potassium channel interactors and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/350614
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 39
[patent_no_of_words] => 85197
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689581.pdf
[firstpage_image] =>[orig_patent_app_number] => 09350614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350614 | Potassium channel interactors and uses therefor | Jul 8, 1999 | Issued |
Array
(
[id] => 6032827
[patent_doc_number] => 20020019020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'METHODS FOR TREATING CARDIOVASCULAR DISORDERS'
[patent_app_type] => new
[patent_app_number] => 09/350874
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 27097
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019020.pdf
[firstpage_image] =>[orig_patent_app_number] => 09350874
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/350874 | METHODS FOR TREATING CARDIOVASCULAR DISORDERS | Jul 8, 1999 | Abandoned |
Array
(
[id] => 1416832
[patent_doc_number] => 06514725
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'STAT function-regulatory protein'
[patent_app_type] => B1
[patent_app_number] => 09/341349
[patent_app_country] => US
[patent_app_date] => 1999-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 10119
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09341349
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341349 | STAT function-regulatory protein | Jul 8, 1999 | Issued |
Array
(
[id] => 1520499
[patent_doc_number] => 06413741
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Human elk a voltage-gated potassium channel subunit'
[patent_app_type] => B1
[patent_app_number] => 09/343494
[patent_app_country] => US
[patent_app_date] => 1999-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 23084
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09343494
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/343494 | Human elk a voltage-gated potassium channel subunit | Jun 29, 1999 | Issued |
Array
(
[id] => 1583984
[patent_doc_number] => 06358505
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'G-CSF receptor agonists'
[patent_app_type] => B1
[patent_app_number] => 09/344837
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 42384
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 644
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09344837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/344837 | G-CSF receptor agonists | Jun 24, 1999 | Issued |
| 09/335150 | CHIMERIC CHEMOKINE-ANTIGEN POLYPEPTIDES AND USES THEREFOR | Jun 16, 1999 | Abandoned |
Array
(
[id] => 4272399
[patent_doc_number] => 06323177
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Interaction of reelin with very low density lipoprotein (VLDL) receptor for screening and therapies'
[patent_app_type] => 1
[patent_app_number] => 9/334220
[patent_app_country] => US
[patent_app_date] => 1999-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28398
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323177.pdf
[firstpage_image] =>[orig_patent_app_number] => 334220
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/334220 | Interaction of reelin with very low density lipoprotein (VLDL) receptor for screening and therapies | Jun 15, 1999 | Issued |
| 09/329331 | CHEMOTACTIC CYTOKINE III | Jun 9, 1999 | Abandoned |
| 09/308439 | LOCAL USE OF IL-1RA IN CORNEAL TRANSPLANT REJECTION OR DISORDERS OF THE EYE | Jun 6, 1999 | Abandoned |
Array
(
[id] => 1260389
[patent_doc_number] => 06663864
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease'
[patent_app_type] => B1
[patent_app_number] => 09/325825
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 10348
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/663/06663864.pdf
[firstpage_image] =>[orig_patent_app_number] => 09325825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325825 | Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease | Jun 3, 1999 | Issued |
| 09/322580 | MAMMALIAN CHEMOKINES AND RECEPTORS; REAGENTS; USES | May 26, 1999 | Abandoned |
Array
(
[id] => 1575746
[patent_doc_number] => 06469154
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Fluorescent protein indicators'
[patent_app_type] => B1
[patent_app_number] => 09/316919
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 21869
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09316919
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316919 | Fluorescent protein indicators | May 20, 1999 | Issued |
Array
(
[id] => 1223522
[patent_doc_number] => 06699687
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Circularly permuted fluorescent protein indicators'
[patent_app_type] => B1
[patent_app_number] => 09/316920
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 21853
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699687.pdf
[firstpage_image] =>[orig_patent_app_number] => 09316920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316920 | Circularly permuted fluorescent protein indicators | May 20, 1999 | Issued |
Array
(
[id] => 1355595
[patent_doc_number] => 06576608
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'Methods of using VEGF-related protein'
[patent_app_type] => B1
[patent_app_number] => 09/313299
[patent_app_country] => US
[patent_app_date] => 1999-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 27460
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576608.pdf
[firstpage_image] =>[orig_patent_app_number] => 09313299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/313299 | Methods of using VEGF-related protein | May 16, 1999 | Issued |
Array
(
[id] => 956144
[patent_doc_number] => 06955894
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-10-18
[patent_title] => 'Method for producing TNF receptor releasing enzyme'
[patent_app_type] => utility
[patent_app_number] => 09/700354
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15736
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/955/06955894.pdf
[firstpage_image] =>[orig_patent_app_number] => 09700354
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/700354 | Method for producing TNF receptor releasing enzyme | May 13, 1999 | Issued |